GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bayer AG (XTER:BAYN) » Definitions » Short Interest

Bayer AG (XTER:BAYN) Short Interest


View and export this data going back to 1953. Start your Free Trial

What is Bayer AG Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Bayer AG's Short Interest

For the Drug Manufacturers - General subindustry, Bayer AG's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bayer AG's Short Interest Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bayer AG's Short Interest distribution charts can be found below:

* The bar in red indicates where Bayer AG's Short Interest falls into.


Bayer AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bayer AG (XTER:BAYN) » Definitions » Short Interest
Comparable Companies
INFU STAA LMAT COO ZJYL MMSI WST AVTR STVN ALGN LLY OCSE:NOVO B JNJ ABBV MRK XSWX:ROG XSWX:NOVN LSE:AZN AMGN PFE
Traded in Other Exchanges
BAYZF:USA BAYRY:USA BAYN:Romania BAY:Poland 1BAYN:Italy BAYER:Hungary 0P6S:UK BAYNd:UK BAYN:Germany BAYA:Germany BAYN:Germany BAYN:Germany BAYA:Germany BAYN:Bulgaria BAYN:Austria
Address
Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Website
https://www.bayer.com
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm also has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through its 2018 acquisition of Monsanto.